Abstract
Purpose
In this study we investigate the relationship between 18F-fluorodeoxyglucose (FDG) metabolism and future aneurysm expansion measured by serial duplex ultrasound. Current screening programmes are increasing the identification of patients with abdominal aortic aneurysm (AAA). The management of these patients remains challenging and methods of risk stratification are sought.
Methods
Thirty-four consecutive patients [31 men, 3 women, median age 75 years, interquartile range (IQR) 71–78] with aortic aneurysms under routine surveillance with serial ultrasound were prospectively recruited for 18F-FDG positron emission tomography (PET)/CT. A whole vessel type analysis was performed measuring the highest aortic wall 18F-FDG uptake (standardized uptake value or SUVmax), and target to background ratio (TBR) for each axial image and median SUVmax and TBR value were calculated. Institutional Review Board permission and informed patient consent were obtained.
Results
Nine patients failed to undergo 12-month follow-up study (deceased n = 2, withdrew n = 1, failed to attend ultrasound scan n = 5, emergency aneurysm repair n = 1) leaving 25 patients for analysis. The median whole vessel SUVmax was 1.70 (IQR 1.45–2.08). The median whole vessel TBR was 1.15 (IQR 1.00–1.40). The median aneurysm expansion at 12 months was 2.0 mm (IQR 0.5–5.0). The correlation (r) between 18F-FDG SUVmax and ultrasound expansion at 1 year was −0.501 (p = 0.011).
Conclusion
The preliminary findings from this observational longitudinal pilot study suggest that there is an inverse trend between 18F-FDG uptake on PET and future AAA expansion. Aortic aneurysms with lower metabolic activity may therefore be more likely to expand.
Similar content being viewed by others
References
Thompson AR, Cooper JA, Ashton HA, Hafez H. Growth rates of small abdominal aortic aneurysms correlate with clinical events. Br J Surg 2010;97:37–44.
Schlösser FJ, Tangelder MJ, Verhagen HJ, van der Heijden GJ, Muhs BE, van der Graaf Y, et al. Growth predictors and prognosis of small abdominal aortic aneurysms. J Vasc Surg 2008;47:1127–33.
Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation 2008;117:1883–9.
Kuivaniemi H, Platsoucas CD, Tilson 3rd MD. Aortic aneurysms: an immune disease with a strong genetic component. Circulation 2008;117:242–52.
Fillinger M. Who should we operate on and how do we decide: predicting rupture and survival in patients with aortic aneurysm. Semin Vasc Surg 2007;20:121–7.
McMillan WD, Pearce WH. Inflammation and cytokine signaling in aneurysms. Ann Vasc Surg 1997;11:540–7.
Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 2003;229:831–7.
Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 2002;105:2708–11.
Tawakol A, Migrino RQ, Bashian GG, Bedri S, Vermylen D, Cury RC, et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 2006;48:1818–24.
Tahara N, Imaizumi T, Virmani R, Narula J. Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med 2009;50:331–4.
Ogawa M, Magata Y, Kato T, Hatano K, Ishino S, Mukai T, et al. Application of 18F-FDG PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med 2006;47:1845–50.
Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 2006;48:1825–31.
Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M, et al. (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol 2007;50:892–6.
Blockmans D, Coudyzer W, Vanderschueren S, Stroobants S, Loeckx D, Heye S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology 2008;47:1179–84.
Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 2008;67:1030–3.
Sakalihasan N, Van Damme H, Gomez P, Rigo P, Lapiere CM, Nusgens B, et al. Positron emission tomography (PET) evaluation of abdominal aortic aneurysm (AAA). Eur J Vasc Endovasc Surg 2002;23:431–6.
Reeps C, Essler M, Pelisek J, Seidl S, Eckstein HH, Krause BJ. Increased 18F-fluorodeoxyglucose uptake in abdominal aortic aneurysms in positron emission/computed tomography is associated with inflammation, aortic wall instability, and acute symptoms. J Vasc Surg 2008;48:417–23.
Harris M. The NHS AAA Screening Programme Annual Report, 2009–10. http://aaa.screening.nhs.uk/annual_report. Accessed 1 Nov 2010.
Thapar A, Cheal D, Hopkins T, Ward S, Shalhoub J, Yusuf SW. Internal or external wall diameter for abdominal aortic aneurysm screening? Ann R Coll Surg Engl 2010;92:503–5.
Menezes LJ, Kotze CW, Hutton BF, Endozo R, Dickson JC, Cullum I, et al. Vascular inflammation imaging with 18F-FDG PET/CT: when to image? J Nucl Med 2009;50:854–7.
Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong CH, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med 2008;49:871–8.
Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging 2009;2:107–15.
Fillinger MF, Racusin J, Baker RK, Cronenwett JL, Teutelink A, Schermerhorn ML, et al. Anatomic characteristics of ruptured abdominal aortic aneurysm on conventional CT scans: implications for rupture risk. J Vasc Surg 2004;39:1243–52.
Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, et al. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg 2009;50(4 Suppl):S2–49.
Xu XY, Borghi A, Nchimi A, Leung J, Gomez P, Cheng Z, et al. High levels of 18F-FDG uptake in aortic aneurysm wall are associated with high wall stress. Eur J Vasc Endovasc Surg 2010;39:295–301.
Kotze CW, Menezes LJ, Endozo R, Groves AM, Ell PJ, Yusuf SW. Increased metabolic activity in abdominal aortic aneurysm detected by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography/computed tomography (PET/CT). Eur J Vasc Endovasc Surg 2009;38:93–9.
Truijers M, Kurvers HA, Bredie SJ, Oyen WJ, Blankensteijn JD. In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall. J Endovasc Ther 2008;15:462–7.
Tawakol A, Migrino RQ, Hoffmann U, Abbara S, Houser S, Gewirtz H, et al. Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography. J Nucl Cardiol 2005;12:294–301.
Wilson WR, Anderton M, Schwalbe EC, Jones JL, Furness PN, Bell PR, et al. Matrix metalloproteinase-8 and -9 are increased at the site of abdominal aortic aneurysm rupture. Circulation 2006;113:438–45.
Choke E, Thompson MM, Dawson J, Wilson WR, Sayed S, Loftus IM, et al. Abdominal aortic aneurysm rupture is associated with increased medial neovascularization and overexpression of proangiogenic cytokines. Arterioscler Thromb Vasc Biol 2006;26:2077–82.
Menezes LJ, Kayani IA, Ben-Haim S, Hutton B, Ell PJ, Grove AM. What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque. Atherosclerosis 2010;211:136–40.
Zhu AX, Meyerhardt JA, Blaszkowsky LS, Kambadakone AR, Muzikansky A, Zheng H, et al. Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol 2010;11:48–54.
Taggart DR, Han MM, Quach A, Groshen S, Villablanca JG, Jackson HA, et al. Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma. J Clin Oncol 2009;27:5343–9.
http://clinicaltrials.gov/ct2/show/NCT00172419. Accessed Jan 2010.
Kato K, Nishio A, Kato N, Usami H, Fujimaki T, Murohara T. Uptake of 18F-FDG in acute aortic dissection: a determinant of unfavorable outcome. J Nucl Med 2010;51:674–81.
Reeps C, Pelisek J, Bundschuh RA, Gurdan M, Zimmermann A, Ockert S, et al. Imaging of acute and chronic aortic dissection by 18F-FDG PET/CT. J Nucl Med 2010;51:686–91.
Reeps C, Gee MW, Maier A, Pelisek J, Gurdan M, Wall W, et al. Glucose metabolism in the vessel wall correlates with mechanical instability and inflammatory changes in a patient with a growing aneurysm of the abdominal aorta. Circ Cardiovasc Imaging 2009;2:507–9.
Astrand H, Rydén-Ahlgren A, Sandgren T, Länne T. Age-related increase in wall stress of the human abdominal aorta: an in vivo study. J Vasc Surg 2005;42:926–31.
Tahara N, Kai H, Nakaura H, Mizoguchi M, Ishibashi M, Kaida H, et al. The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography. Eur Heart J 2007;28:2243–8.
Rudd JH, Elkhawad M, Fayad ZA. Comment on: Vascular imaging with 18F-FDG PET/CT: optimal 18F-FDG circulation time? J Nucl Med 2009;50:1560.
Kuehl H, Eggebrecht H, Boes T, Antoch G, Rosenbaum S, Ladd S, et al. Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation. Heart 2008;94:1472–7.
Speelman L, Bosboom EMH, Schurink GWH, Buth J, Breeuwer M, Jacobs MJ, et al. Initial stress and nonlinear material behavior in patient-specific AAA wall stress analysis. J Biomech 2009;42:1713–9.
Tsai TT, Nienaber CA, Eagle KA. Acute aortic syndromes. Circulation 2005;112:3802–13.
Sakalihasan N, Hustinx R, Limet R. Contribution of PET scanning to the evaluation of abdominal aortic aneurysm. Semin Vasc Surg 2004;17:144–53.
Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol 2006;26:2605–13.
Acknowledgments
We thank Dr. Gareth Ambler, Biostatistician, Joint UCLH/UCL Research and Development Department, for statistical advice. Furthermore, we thank the members of the vascular unit at the Royal Sussex County Hospital, Brighton for contributing to this study.
Funding
This study was part funded by the Sussex Stroke and Circulation Fund and the Royal College of Radiologists. UCLH/UCL receives a proportion of funding from the Department of Health’s NIHR Biomedical Research Centre’s funding scheme.
Conflicts of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kotze, C.W., Groves, A.M., Menezes, L.J. et al. What is the relationship between 18F-FDG aortic aneurysm uptake on PET/CT and future growth rate?. Eur J Nucl Med Mol Imaging 38, 1493–1499 (2011). https://doi.org/10.1007/s00259-011-1799-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-011-1799-8